Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2022 Jul 05
"Who needs a mean dose if you can FLAME?".
Related Questions
The FLAME trial demonstrated a significant improvement in 5-year DFS, without any significant changes in overall toxicities, when patients being treat...
New comment by Radiation Oncologist at Christus St Vincent ( May 30, 2024)
Thank you. This sounds like a reasonable and safe plan to follow.